Nonpeptide arginine vasopressin antagonists for both V1A and V2 receptors: synthesis and pharmacological properties of 2-phenyl-4'-(2, 3, 4, 5-tetrahydro-1H-1, 5- …

A Matsuhisa, H Koshio, K Sakamoto…

Index: Chemical and Pharmaceutical Bulletin, , vol. 46, # 10 p. 1566 - 1579

Full Text: HTML

Citation Number: 30

Abstract

... Chemistry The synthetic pathway for the preparation of the benzodi- azepine derivatives listed in Tables 1—5 is shown in Charts l»—3. 1,4-Benzodiazepine derivatives were synthesized ac- cording to the route shown in Chart 1 ... 1998 Pharmaceutical Society of ... 1570 Vol. ...

Related Articles:

Nonpeptide arginine vasopressin antagonists for both V1A and V2 receptors: synthesis and pharmacological properties of 2-phenyl-4'-(2, 3, 4, 5-tetrahydro-1H-1, 5- …

[Matsuhisa, Akira; Koshio, Hiroyuki; Sakamoto, Kenichiro; Taniguchi, Nobuaki; Yatsu, Takeyuki; Tanaka, Akihiro Chemical and Pharmaceutical Bulletin, 1998 , vol. 46, # 10 p. 1566 - 1579]

A Scalable Process for the Synthesis of 2-Methyl-1, 4, 5, 6-tetrahydroimidazo [4, 5-d][1] benzazepine Monohydrate and 4-[(Biphenyl-2-ylcarbonyl) amino] benzoic Acid: …

[Tsunoda, Takashi; Yamazaki, Atsuki; Mase, Toshiyasu; Sakamoto, Shuichi Organic Process Research and Development, 2005 , vol. 9, # 5 p. 593 - 598]

Selective Fluorescent Nonpeptidic Antagonists For Vasopressin V2 GPCR: Application To Ligand Screening and Oligomerization Assays.

[Journal of Medicinal Chemistry, , vol. 55, # 20 p. 8588 - 8602]

More Articles...